CAMBRIDGE, Britain (AP) _ Astrazeneca PLC (AZN) on Thursday reported a fourth-quarter loss of $346 million, after reporting a profit in the same period a year earlier.
The Cambridge, Britain-based company said it had a loss of 11 cents per share. Earnings, adjusted for non-recurring costs, were 84 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 77 cents per share.
The pharmaceutical posted revenue of $12.01 billion in the period.
For the year, the company reported profit of $112 million, or 4 cents per share. Revenue was reported as $37.42 billion.
Astrazeneca shares have declined nearly 2% since the beginning of the year. The stock has increased 13% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at https://www.zacks.com/ap/AZN